Imuran Dosing in Crohn's Disease Study

PHASE2TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Crohn's Disease
Interventions
DRUG

Azathioprine weight-based dose

DRUG

Azathioprine individualised dose

Trial Locations (15)

10029

Mt. Sinai Medical Center, New York

11021

Long Island Clinical Research Assoc., Great Neck

15213

University of Pittsburgh, Pittsburgh

21287

Johns Hopkins University, Baltimore

27514

University of North Carolina Chapel Hill, Chapel Hill

30342

Atlanta Gastroenterology Associates, LLC, Atlanta

45229

Cincinnati Children's Hospital, Cincinnati

55805

Duluth Clinic, Duluth

55905

Mayo Clinic, Rochester

60637

University of Chicago Pediatric Gastroenterology, Chicago

University of Chicago, Chicago

90048

Cedars-Sinai Medical Center, Los Angeles

T6G2X8

University of Alberta, Edmonton

N6A5A5

London Health Sciences Centre, London

M5G 1X8

Hospital for Sick Children, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Prometheus Laboratories

INDUSTRY

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH